STOCKHOLM, Sweden, Jan. 22, 2002 (PRIMEZONE) -- Pyrosequencing:
Date: Monday, February 4, 2002
Time: 10:30 a.m. GMT
Place: Financial Dynamics
London, UK
Erik Wallden, President and Chief Executive Officer of Pyrosequencing AB (Stockholm: PYRO A) would like to invite you to an investor update and an overview of opportunities in the molecular diagnostics market.
The guest speaker will be Dr. Richard Barker, former President of Chiron Diagnostics, who will discuss the opportunities and challenges in the molecular diagnostics market.
Jerry Williamson, VP, Head of Molecular Diagnostics at Pyrosequencing, will provide an overview of Pyrosequencing's approach to this dynamic market. The presentation will be followed by questions and discussion. A buffet lunch will be served.
We would be delighted if you could join us in person at the offices of Financial Dynamics, 26 Southampton Buildings, London WC2. For those unable to attend, the meeting will be recorded and available on Pyrosequencing's Web site at www.pyrosequencing.com from 4 p.m. GMT on the same day.
For further information / RSVP please contact Claire Rowell at Financial Dynamics on +44 (0) 20 7269 7285.
Pyrosequencing AB develops, manufactures and sells complete solutions for rapid applied genetic analysis based on its proprietary Pyrosequencingtm Technology, a simple-to-use DNA sequencing technique. Pyrosequencing leads the global market in Applied Genomics with over 120 systems sold to major pharmaceutical and biotech companies and prestigious research institutions worldwide.
This information was brought to you by Waymaker http://www.waymaker.net